Macular Edema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Publisher Name :
Date: 01-Nov-2016
No. of pages: 100
This report is available at upto 40% Discount. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's Report, "Macular Edema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Macular Edema Report is to understand the market and pipeline status of the drugs around the Macular Edema to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Macular Edema. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight's report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Scope:

- A snapshot of the global Market and Phase III therapeutics scenario for Macular Edema.

- A review of the marketed products under prescription for Macular Edema, regulatory information and marketing status.

- Coverage of global patent coverage and detailed commentaries on the US patent challenges.

- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

- Product profiles for marketed products for Macular Edema with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

- Coverage of API Manufacturers for Macular Edema drugs in the United States, Europe and Asian Regions with location details.

- Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Macular Edema drugs.

- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Macular Edema drugs.

- Coverage of Macular Edema Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.

- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.

- Key discontinued Marketed products.

- Global Sales Figure to 2018.

Reasons to buy

- Evaluate the marketing status and exclusivity details of Macular Edema key products to exploit opportunities for generic drug development opportunities.

- Identify and understand important and diverse types of therapeutics under Phase III development for Macular Edema.

- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Macular Edema.

- API intelligence over marketed drugs for Macular Edema and gaining primary intelligence over active ingredients manufacturers across the globe.

- API intelligence over leading Phase III Pipeline drugs.

- Develop and design strategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.

- Understanding the scope of the Phase III Drugs with nil regulatory filings.

- Understanding the chemical route of synthesis of approved drugs for Macular Edema.

- Uncovering opportunities in the rapidly growing US market.

Macular Edema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Table of Contents

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Macular Edema
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Macular Edema
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Macular Edema
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables

Macular Edema Therapeutic Market, US, Marketed Drugs by Application Type, 2016
Macular Edema Therapeutic Market, US, Marketed Drugs by Marketing Status, 2016
Macular Edema Therapeutic Market, US, (Year), 2016
Macular Edema Marketed Drugs, API Manufacturers by US DMF Status, 2016
Macular Edema Marketed Drugs, US DMF Status Drug Specific (Number), 2016
Macular Edema Drugs, API Manufacturers, Europe by Country, 2016
Macular Edema Drugs, API Manufacturers, India by State, 2016
Macular Edema Drugs, API Manufacturers, China by Province, 2016
Macular Edema Drugs, API Manufacturers by Geography 2016
Macular Edema Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2016
Macular Edema Therapeutic Market, Global Sales-2018 (in million USD)
API Manufacturers for Drug, 2016
Phase III Drugs for Macular Edema, 2016
Discontinued Drugs for Macular Edema, 2016

List of Figures

Macular Edema Therapeutic Market, US, Marketed Drugs by Application Type (%), 2016
Macular Edema Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2016
Macular Edema Therapeutic Market, US, (Year), 2016
Macular Edema Marketed Drugs, API Manufacturers by US DMF Status (%), 2016
Macular Edema Marketed Drugs, US DMF Status Drug Specific (Number), 2016
Macular Edema Drugs, API Manufacturers, Europe by Country, 2016
Macular Edema Drugs, API Manufacturers, India by State, 2016
Macular Edema Drugs, API Manufacturers, China by Province, 2016
Macular Edema Drugs, API Manufacturers by Geography 2016
Macular Edema Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2016
Macular Edema Therapeutic Market, Global Sales 2018 (in million USD)
Drug, Patent/Exclusivity Expiry (Year), 2016
  • Ophthalmology Drug Development Pipeline Review, 2016
    Published: 01-Dec-2016        Price: US 3995 Onwards        Pages: 633
    Ophthalmology disorders are associated with the eyes and visual system. If left untreated, serious long-term co-morbidities such as diabetes, and particularly blindness, can arise. Although there are a number of treatments approved in ophthalmology, there are currently no curative therapies for any of these indications. In particular, there are strong unmet needs within age-related macular degeneration and glaucoma, which can lead to blindness if not adequately treated. Although there......
  • Global Dry Eye Syndrome Drug Market Research Report 2016
    Published: 30-Nov-2016        Price: US 2900 Onwards        Pages: 102
    Notes: Production, means the output of Dry Eye Syndrome Drug Revenue, means the sales value of Dry Eye Syndrome Drug This report studies Dry Eye Syndrome Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Allergan - Novartis - Santen - Shire - Otsuka ......
  • Global Conjunctivitis Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 30-Nov-2016        Price: US 3480 Onwards        Pages: 118
    Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.Conjunctivitis is more commonly referred to as pink eye. The whites of the eyes appear pink or red when the conjunctiva (the transparent membrane which lines part of the eyeball) becomes inflamed or infected......
  • United States Age-Related Macular Degeneration (AMD) Market Report 2016
    Published: 23-Nov-2016        Price: US 3800 Onwards        Pages: 97
    Notes: Sales, means the sales volume of Age-Related Macular Degeneration (AMD) Revenue, means the sales value of Age-Related Macular Degeneration (AMD) This report studies sales (consumption) of Age-Related Macular Degeneration (AMD) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Acucela - Alimera Sciences, Inc. - Bayer Ag. - F. Hoffmann-La Roche Ltd - Gla......
  • United States Eye Drops Market Report 2016
    Published: 23-Nov-2016        Price: US 3800 Onwards        Pages: 104
    Notes: Sales, means the sales volume of Eye Drops Revenue, means the sales value of Eye Drops This report studies sales (consumption) of Eye Drops in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Abott Medical Optics Inc - Akorn Inc - Johnson & Johnson - Bausch and Lomb - Novartis International AG - Allergan, Inc. - Santen Pharmaceuticals......
  • United States Ophthalmology Drugs Market Report 2016
    Published: 23-Nov-2016        Price: US 3800 Onwards        Pages: 121
    Notes: Sales, means the sales volume of Ophthalmology Drugs Revenue, means the sales value of Ophthalmology Drugs This report studies sales (consumption) of Ophthalmology Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Pfizer Inc - Hoya Corporation - Bayer - Novartis International AG - Abbott Medical Optics, Inc. - Ziemer Ophthalmic Systems AG......
  • Global Optic Neuritis Market Research Report 2016
    Published: 17-Nov-2016        Price: US 2900 Onwards        Pages: 103
    Notes: Production, means the output of Optic Neuritis Revenue, means the sales value of Optic Neuritis This report studies Optic Neuritis in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Sicor Societa' Italiana Corticosteroidi S.R.L - Allergan Pharmaceuticals Ireland......
  • Macular Edema - Pipeline Review, H2 2016
    Published: 16-Nov-2016        Price: US 2000 Onwards        Pages: 63
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema - Pipeline Review, H2 2016, provides an overview of the Macular Edema (Ophthalmology) pipeline landscape.Macular edema is swelling or fluid retention in a specialized part of the retina called the macula. Symptoms of macular edema include blurred or wavy central vision and/or colors appear changed. There are many causes of macular edema. It is frequently associated with diabetes, where damaged bl......
  • Diabetic Retinopathy - Pipeline Review, H2 2016
    Published: 16-Nov-2016        Price: US 2000 Onwards        Pages: 237
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Retinopathy - Pipeline Review, H2 2016, provides an overview of the Diabetic Retinopathy (Metabolic Disorders) pipeline landscape.Diabetic retinopathy is a complication of diabetes that affects the eyes. Diabetic retinopathy symptoms may include spots or dark strings floating in your vision (floaters), blurred vision, fluctuating vision, vision loss and difficulty with color perception. The predisposi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs